AR038189A1 - Proceso para la preparacion de intermediarios de antagonistas de integrina - Google Patents

Proceso para la preparacion de intermediarios de antagonistas de integrina

Info

Publication number
AR038189A1
AR038189A1 ARP030100156A ARP030100156A AR038189A1 AR 038189 A1 AR038189 A1 AR 038189A1 AR P030100156 A ARP030100156 A AR P030100156A AR P030100156 A ARP030100156 A AR P030100156A AR 038189 A1 AR038189 A1 AR 038189A1
Authority
AR
Argentina
Prior art keywords
preparation
integrine
intermediaries
antagonist
structural formula
Prior art date
Application number
ARP030100156A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of AR038189A1 publication Critical patent/AR038189A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Proceso para la preparación de 2,5-di-(3-aminopropil)piridina, de fórmula estructural (1) que es útil en la síntesis de antagonistas del receptor de integrina alfa v beta 3. Además se proporcionan intermediarios útiles obtenidos del proceso. Reivindicación 1: un proceso para la preparación del compuesto de fórmula estructural (1) que comprende la etapa de hidrogenar el compuesto de la fórmula estructural (2).
ARP030100156A 2002-01-29 2003-01-20 Proceso para la preparacion de intermediarios de antagonistas de integrina AR038189A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35260102P 2002-01-29 2002-01-29

Publications (1)

Publication Number Publication Date
AR038189A1 true AR038189A1 (es) 2005-01-05

Family

ID=27663113

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100156A AR038189A1 (es) 2002-01-29 2003-01-20 Proceso para la preparacion de intermediarios de antagonistas de integrina

Country Status (4)

Country Link
US (1) US6914144B2 (es)
AR (1) AR038189A1 (es)
TW (1) TW200304439A (es)
WO (1) WO2003064390A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8372399B2 (en) * 2006-08-31 2013-02-12 Cardiac Pacemakers, Inc. Bispecific antibodies and agents to enhance stem cell homing
US8636995B2 (en) * 2006-08-31 2014-01-28 Cardiac Pacemakers, Inc. Methods and devices to regulate stem cell homing
US20080058922A1 (en) * 2006-08-31 2008-03-06 Cardiac Pacemakers, Inc. Methods and devices employing vap-1 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19741876A1 (de) 1997-09-23 1999-03-25 Basf Ag Verfahren zur selektiven Herstellung racemischer Metallocenkomplexe
US6017926A (en) 1997-12-17 2000-01-25 Merck & Co., Inc. Integrin receptor antagonists
EP1230240B1 (en) * 1999-11-08 2003-07-23 Merck & Co., Inc. Process and intermediates for the preparation of imidazolidinone alpha v integrin antagonists
GB2356630A (en) * 1999-11-10 2001-05-30 Merck & Co Inc Intermediates used in the preparation of tetrahydronaphthyridine
JP4787447B2 (ja) * 2000-01-20 2011-10-05 メルク・シャープ・エンド・ドーム・コーポレイション αｖインテグリン受容体拮抗薬

Also Published As

Publication number Publication date
WO2003064390A1 (en) 2003-08-07
US6914144B2 (en) 2005-07-05
TW200304439A (en) 2003-10-01
US20030176707A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
ECSP066773A (es) Intermediarios de quinolina como inhibidores de receptores de tirosina quinasas y la síntesis de los mismos
AR064165A1 (es) Un procedimiento para la preparacion de capecitabina e intermediarios utilizables en dicho procedimiento
ITMI20050801A1 (it) Procedimento per la preparazione di telmisartan
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
AR006545A1 (es) Compuestos sustitutos de las catecolaminas, utiles como antagonistas beta3, composiciones farmaceuticas que los contienen y compuestos intermediarios deaplicacion exclusiva en la preparacion de dichos compuestos
NO20060195L (no) Kinolylamidderivater som CCR-5-antagonister
GT200500296A (es) Sintesis asimetrica de derivados del dehidrobenzofurano
ATE439345T1 (de) Zwischenprodukte für die herstellung von harnstoffderivaten mit muskarinrezeptor- antagonistischer aktivität
UY26974A1 (es) Agonistas del receptor beta3 adrenérgico y usos de los mismos
CR8475A (es) Fenilalanina-amidas sustituidas por benzoilo
WO2005030712A3 (en) Thrombin receptor antagonists
WO2004048345A3 (en) 2,5-diketopiperazines for the treatment of obesity
MA27991A1 (fr) Derives d'aminoquinoline et leur utilisation comme ligands d'adenosine a3
EA200500536A1 (ru) Антагонисты рецептора pgd2 для лечения воспалительных заболеваний
SMAP200600024A (it) 2,6-Biseteroaril-4-amminopirimidine come antagonisti del recettore dell'adenosia
DE602005021258D1 (de) Biphenylverbindungen geeignet für die Synthese von Muscarinrezeptorantagonisten
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ATE386740T1 (de) Beta-3 adrenergische agonisten
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
EA200400454A1 (ru) Мускариновые агонисты
PA8782901A1 (es) "nuevos compuestos ligandos del receptor de la adenosina a3"
ECSP045291A (es) Preparación de ácido n1-(2'-piridil)-1,2-propanodiamino sulfámico y su uso en la síntesis de piperazinas biológicamente activas
ECSP088878A (es) Proceso para la preparación de indazolil ureas que inhiben receptores de vanilloides del subtipo 1 (vr1)
AR038189A1 (es) Proceso para la preparacion de intermediarios de antagonistas de integrina

Legal Events

Date Code Title Description
FB Suspension of granting procedure